RKLB 8-K Current Reports

Rocket Lab 8-K Report, Regulation FD Disclosure (Oct 14, 2026)

Rocket Lab (RKLB) furnished an 8-K on October 14, 2026 disclosing an update to its Neutron medium-lift rocket program. The company now expects the inaugural Neutron launch to occur in 2027, rather than the previously anticipated timeframe, which it attributes to continued development work and the incorporation of process improvements. Management says the program is progressing through key manufacturing and testing milestones. The update was issued as a press release (Exhibit 99.1) and accompanied by an investor presentation on the company's investor relations website. For investors, the central takeaway is a delay in the timing of Neutron's first flight. Neutron is a central pillar of Rocket Lab's growth narrative as a reusable medium-lift vehicle that would extend the company beyond its Electron and HASTE small-lift business, so slippage affects the timing of expected Neutron revenue and the broader medium-lift opportunity. The filing does not quantify any financial impact, revised revenue expectations, updated cost estimates, or changes to guidance, so those details would need to come from the accompanying presentation or future earnings disclosures. The filing is a Regulation FD disclosure with Items 7.01 and 8.01, and the company states that the information is furnished rather than filed for Section 18 purposes. The company has not provided a new specific launch date and has committed only to further updates as work continues. Investors should watch for those updates, the detailed presentation, and any changes to the company's forward-looking financial commentary.

Oct 14, 2026 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Sep 15, 2026)

Rocket Lab (RKLB) reported on September 15, 2026 that it has fully funded its pending acquisition of Iridium Communications. The company completed its at-the-market (ATM) equity program, raising approximately $1.944 billion in gross proceeds from the sale of about 29.3 million shares before commissions and expenses. Management says these proceeds, together with the amended Iridium credit facility and other available liquidity, are sufficient to cover the anticipated cash consideration and related payments at closing. The company expects the transaction to close in mid-2027, subject to regulatory approvals and stockholder approval of the Iridium holders. On the debt side, Iridium and its lenders (at least the Required Lenders) signed Consent and Amendment No. 4 to the existing $1.775 billion term loan. The amendment carves the Transaction out of the change-of-control definition, so the loans can remain outstanding after closing, and it adds a downstream unsecured guarantee from Rocket Lab USA, Inc. at closing. Post-closing pricing steps up to SOFR plus 2.50%-3.00% (or base rate plus 1.50%-2.00%) based on Rocket Lab's credit ratings, and a 1.00% exit fee applies to prepayments after the first anniversary of closing. The $3.6 billion 364-day bridge commitment was terminated in full, removing a bridge-financing overhang. For investors, the key takeaways are reduced financing risk and a clearer capital structure, offset by meaningful dilution from the ATM issuance and a higher cost of the permanent Iridium debt once the deal closes. The filing does not disclose Iridium's or Rocket Lab's standalone financial results, purchase price breakdown, or pro forma leverage, so those figures should be sought in the S-4/final prospectus.

Sep 15, 2026 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Aug 13, 2026)

Rocket Lab (RKLB) disclosed a replacement at-the-market (ATM) equity program with Deutsche Bank Securities and Wells Fargo Securities, under which it may sell common stock with an aggregate offering price of up to $1,944,369,826. The new agreement replaces the prior equity distribution agreement dated May 20, 2026, and carries forward the unsold amount under that program rather than adding capacity. The company also may enter into forward sale agreements, including initially priced and collared forward transactions. Sales commissions are capped at 2.00% of gross proceeds, and the program may be terminated on two days' notice. The company says the net proceeds will fund cash payments for its proposed acquisition of Iridium Communications and reduce its committed bridge facility. The offering is not conditioned on completing the Iridium deal, and the company says it will use any excess proceeds for growth, potential acquisitions, and general corporate purposes. A concurrent press release on the Iridium acquisition reports several milestones. The Hart-Scott-Rodino waiting period expired at 11:59 p.m. ET on August 12, 2026, which clears U.S. antitrust review. Rocket Lab filed its Form S-4 registration statement, which is not yet effective, and FCC transfer-of-control applications were filed on August 10, 2026. The company holds a $3.6 billion 364-day senior secured bridge commitment and plans to replace it with permanent debt and equity. It also intends to seek lender consents to amend Iridium's $1.775 billion term loan so that facility can stay in place, which would reduce the bridge commitment. There is no assurance those consents will be obtained. For investors, the key points are the scale of potential dilution, the reliance on equity and debt refinancing to fund a large acquisition, and the execution risk tied to lender consents, S-4 effectiveness, and shareholder approvals. Because the ATM sales can be suspended at any time and are subject to price and volume parameters, the timing and size of actual issuance are uncertain. Investors should monitor future prospectus supplements, the S-4 review process, and any Iridium lender consent results.

Aug 13, 2026 8-K

Rocket Lab 8-K Report, Corporate Update (Aug 13, 2026)

Rocket Lab (RKLB) filed this Form 8-K on August 13, 2026 to furnish financial information tied to its pending acquisition of Iridium Communications (IRDM), agreed June 28, 2026. Under the Merger Agreement, Iridium holders would receive $27.00 in cash plus Rocket Lab stock at a floating exchange ratio: 0.4000 shares if Rocket Lab's 10-day VWAP is at or below $67.50, 0.2400 at or above $112.50, and $27.00 divided by the VWAP in between. Using the 10-day VWAP ending August 7, 2026 of $69.33, the exchange ratio is 0.3894, implying about 41.3 million new Rocket Lab shares and an estimated total purchase consideration of roughly $7.59 billion. The filing itself contains no new operating guidance; its substance is the Iridium audited and unaudited financials (incorporated by reference) and the pro forma combined statements. The pro forma statements show the financing burden clearly. The deal is funded with a $3.6 billion 364-day bridge facility at an effective rate of about 8.0%, which the filing says Rocket Lab intends to replace with permanent financing, though terms are not yet determinable. Pro forma combined cash falls to about $1.0 billion from $2.1 billion at June 30, 2026, and pro forma interest expense rises to about $143 million for the six months ended June 30, 2026 and $312 million for FY2025. On a pro forma basis, Rocket Lab's combined results show a six-month net loss of $154.7 million (EPS of -$0.23) and a FY2025 net loss of $203.0 million (EPS of -$0.36), compared with standalone Rocket Lab net losses of $94.3 million and $198.2 million. Pro forma combined revenue is about $879 million for the six months and $1.47 billion for FY2025. The filing also flags several uncertainties: preliminary purchase price allocation with about $2.2 billion of goodwill and $4.3 billion of intangibles (subject to change), a tax-free reorganization treatment that depends on the cash-to-stock mix, a possible reduction in bridge borrowings if Iridium debt amendments are completed, and the acquisition of Aireon by Iridium on July 2, 2026, which adds debt not reflected in these figures. The transaction remains subject to Iridium stockholder approval, regulatory approvals, and the effectiveness of the Form S-4.

Aug 13, 2026 8-K

Material AgreementsRegulation FDExhibits & Filings

Rocket Lab 8-K Report, Financial Results (Aug 10, 2026)

Rocket Lab reported record second-quarter 2026 revenue of $234.1 million, up 62% year-over-year and $34 million above the prior quarter, with record backlog of $2.36 billion (up 137% year-over-year). GAAP net loss narrowed to $49.3 million from $66.4 million a year earlier, and Adjusted EBITDA improved to a loss of $8.8 million from a loss of $27.6 million. GAAP gross margin was about 36.1% (84.6 million on 234.1 million of revenue), while the company reported a non-GAAP gross margin of 41.5%. GAAP operating expenses rose to $142.1 million, driven by higher R&D and SG&A, including $8.6 million of transaction costs. Management said new contracts of more than $1 billion had been signed in Q3 to date, including a $397 million SB-AMTI launch-plus-spacecraft award from the U.S. Space Force. The balance sheet changed substantially. Cash and equivalents rose to $2.13 billion from $829 million at year-end 2025, largely because of $1.53 billion in at-the-market (ATM) equity proceeds in the first half. Shares outstanding increased to about 598 million from about 544 million. Operating cash flow was negative $134 million for the six months, and inventories and receivables grew sharply, reflecting the ramp in production and contract activity. Contract liabilities of $351 million, up from $195 million, indicate substantial customer prepayments supporting the backlog. For Q3 2026, management guided to revenue of $250 million to $265 million, GAAP gross margin of 29% to 31%, non-GAAP gross margin of 35% to 37%, and an Adjusted EBITDA loss of $17 million to $23 million. The company also announced a landmark agreement to acquire Iridium Communications, which would vertically integrate launch, satellite manufacturing, and constellation operations. The Iridium deal, the Neutron first launch timeline (target delivery to the pad in Q4 2026), and the Neutron execution risk are the key items for investors to monitor.

Aug 10, 2026 8-K

Rocket Lab 8-K Report, Material Agreement (Jun 29, 2026)

Rocket Lab (RKLB) has agreed to acquire Iridium Communications (IRDM) in a cash-and-stock merger valued at a notional $54.00 per Iridium share, or an enterprise value of about $8.0 billion. Each Iridium share will receive $27.00 in cash plus Rocket Lab stock under a collared exchange ratio: 0.4000 shares if RKLB's 10-day VWAP is at or below $67.50, a fixed-value ratio of $27.00 divided by the VWAP between $67.50 and $112.50, and 0.2400 shares at or above $112.50. Within the collar, the stock component is worth a fixed $27.00, so Iridium holders are protected from RKLB price moves in that band. Outside it, the value floats: below $67.50 the stock component is worth less than $27.00, and above $112.50 it is worth more. The transaction is structured as a two-step merger intended to qualify as a tax-free reorganization, though that treatment depends on the cash-to-stock value mix at closing. The deal is financed in part by a $3.6 billion 364-day senior secured bridge loan from Deutsche Bank and Wells Fargo, with the balance of the cash component to come from Rocket Lab's balance sheet and other debt or equity sources. Rocket Lab's cash position and leverage will therefore change materially if the deal closes, and the filing does not quantify the total cash requirement or post-closing leverage. Completion requires Iridium stockholder approval, HSR clearance, FCC consent for the transfer of control of Iridium's telecom authorizations, several foreign investment and satellite approvals, and an effective Form S-4 registration covering the RKLB shares to be issued. The outside date is June 28, 2027, extendable to September and December 2027. Iridium owes Rocket Lab a $223.62 million termination fee in specified circumstances, including a superior proposal or an adverse board recommendation change. Iridium's 2025 revenue was $871.7 million with OEBITDA of $495 million (57% margin), per the companies, which Rocket Lab frames as a source of recurring cash flow and accretion. Directors holding about 1.6% of Iridium shares have signed support agreements. Management expects closing in mid-2027.

Jun 29, 2026 8-K

Leadership Changes

Rocket Lab 8-K Report, Executive Changes (Jun 5, 2026)

Rocket Lab Corporation (RKLB) announced a significant leadership change within its finance department through an 8-K filing on June 5, 2026. The company appointed Agostino Ricupati as Vice President, Corporate Controller and Chief Accounting Officer, effective June 3, 2026. Mr. Ricupati brings extensive experience from senior finance and accounting roles at large, publicly traded multinational corporations, including over two decades at Cooper Companies and prior roles at Intel, McAfee, Baxter International, and Arthur Andersen LLP. His appointment is expected to strengthen the company's global accounting operations. This appointment also means Adam C. Spice will transition from his role as principal accounting officer, though he will continue as Chief Financial Officer and principal financial officer. The filing details Mr. Ricupati's compensation package, which includes a base salary of $350,000, potential performance bonuses, a $50,000 sign-on bonus, a temporary housing stipend, and a substantial $3 million restricted stock unit award vesting over four years. Investors should view this as a strategic move to bolster financial oversight and reporting capabilities as Rocket Lab continues its growth trajectory.

Jun 5, 2026 8-K

Shareholder Matters

Rocket Lab 8-K Report, Shareholder Vote Results (May 21, 2026)

Rocket Lab Corp (RKLB) held its 2026 Annual Meeting of Stockholders on May 20, 2026, where several key proposals were voted upon by shareholders. The results indicate strong support for the company's leadership and strategic direction. Notably, all proposals presented received overwhelming approval, suggesting shareholder confidence in the company's management and operational plans. Investors should note the election of Edward H. Frank as a Class II director, the ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2026, and the approval of executive compensation on an advisory basis. A significant proposal that passed overwhelmingly was the approval of a subsidiary merger aimed at streamlining certain corporate actions by eliminating a pass-through voting provision related to Rocket Lab USA, Inc. This move is likely intended to enhance operational flexibility and decision-making efficiency.

May 21, 2026 8-K

Rocket Lab 8-K Report, Corporate Update (May 20, 2026)

Rocket Lab Corporation has entered into an Equity Distribution Agreement with a syndicate of prominent financial institutions, allowing for the potential sale of up to $3 billion of its common stock. This agreement enables the company to raise capital flexibly through various equity financing methods. A key aspect of this arrangement is the incorporation of forward sale agreements, which allow Rocket Lab to potentially receive proceeds from stock sales at a future date, with specific mechanisms designed for both "Initially Priced Forward Transactions" and "Collared Forward Transactions." These forward sale structures offer different pricing mechanisms and settlement options, including potential cash or stock settlements. The "Collared Forward Transactions" introduce a floor and cap price for sales, providing some protection against extreme price volatility during the hedging period. The company retains the right to specify certain trading parameters and to suspend sales under specific conditions, offering a degree of control over the execution. The agreement is underpinned by an effective shelf registration statement, indicating readiness for capital deployment.

May 20, 2026 8-K

Rocket Lab 8-K Report, Corporate Update (May 8, 2026)

Rocket Lab Corporation (RKLB) filed an 8-K on May 8, 2026, primarily detailing the filing of a prospectus supplement related to the resale of shares. These shares, totaling up to 2,277,002, were issued on April 14, 2026, in a private placement connected to the acquisition of Mynaric AG. The filing ensures these shares, previously issued under the Stock Purchase Agreement dated September 25, 2025, can be legally resold by certain selling stockholders. This filing is important for investors as it clarifies the process for secondary market liquidity for a specific block of RKLB shares. While not a direct financial event for the company itself, it signals the completion of a key step in the Mynaric AG acquisition by enabling the resale of shares issued as consideration. Investors should note that the shares are being resold by existing stockholders, not newly issued by the company. The company also included a legal opinion from Goodwin Procter LLP as an exhibit to support the prospectus supplement.

May 8, 2026 8-K

Securities & ListingRegulation FDOther Events+1

Rocket Lab 8-K Report, Financial Results (May 7, 2026)

Rocket Lab (RKLB) reported first-quarter 2026 results that management characterized as a record quarter across revenue, gross margin, and backlog. Revenue reached $200.3M, up 63.5% year over year from $122.6M, and GAAP gross margin expanded to 38.2% (from roughly 28.8% a year earlier). GAAP operating loss narrowed to $55.97M from $59.19M, and net loss improved to $45.0M, or $(0.07) per share, versus $60.6M, or $(0.12), in Q1 2025. Adjusted EBITDA was $(11.8)M, compared with $(30.0)M a year earlier. Backlog rose 20.2% quarter over quarter to $2.2B, and the company cited more than $2B of total liquidity following an at-the-market equity program. The balance sheet strengthened substantially: cash and equivalents rose to $1.21B from $829M, largely from $450M of ATM equity proceeds, and the convertible senior notes fell to $36.9M from $152.4M, likely reflecting conversion or repayment. Operating cash flow was still negative at $(50.3)M, and inventories, receivables, and contract assets all grew, so working-capital needs are rising alongside growth. Share count increased as well, with outstanding common shares rising to about 576M from 544M. Looking ahead, management guided Q2 2026 revenue to $225–240M, GAAP gross margin to 33–35%, and adjusted EBITDA loss to $20–26M. The guidance implies lower GAAP gross margin than Q1 and a wider EBITDA loss, which investors will likely scrutinize. Key strategic items include the Mynaric acquisition (closed), a pending Motiv acquisition, selection for the Space Based Interceptor program under Golden Dome, and the Neutron medium-lift rocket's targeted debut later in 2026. Neutron timing and margin trajectory remain the central execution risks.

May 7, 2026 8-K

Rocket Lab 8-K Report, Unregistered Securities Sale (Apr 14, 2026)

On April 14, 2026, Rocket Lab Corporation (Nasdaq: RKLB) completed its acquisition of Mynaric AG, a Munich-based provider of laser optical communication terminals, for an aggregate consideration value of $155.3 million. The consideration consisted of a nominal cash payment and 2,277,002 shares of Rocket Lab common stock, of which 109,943 shares were placed in an indemnity escrow. The purchase price was based on a $75 million base price plus additional investments made by the Sellers (OC III LVS LIII LP and CO Finance II LVS I LLC) prior to closing, which reduced the earnout the Sellers could otherwise have received. Subject to post-closing adjustments, the Sellers are no longer eligible for further earnout payments. The deal received approval from Germany's Federal Ministry for Economic Affairs and Energy. Strategically, the acquisition adds laser communications to Rocket Lab's space systems portfolio and establishes its first European footprint, with Mynaric remaining headquartered in Munich. Management highlighted that Mynaric supplies CONDOR Mk3 optical terminals for Rocket Lab's $1.3 billion SDA Proliferated Warfighter Space Architecture prime contracts (36 satellites), which gave the company detailed insight into the technology and its scaling potential. Management plans to expand Mynaric's production capacity to address supply-chain bottlenecks in satellite laser communications. The filing is largely administrative, and the 8-K does not provide revenue, margin, or profitability figures for Mynaric, nor a detailed purchase price allocation. Investors should note the dilution from the 2,277,002 newly issued shares, which were issued under a private placement exemption (Section 4(a)(2) / Regulation D), and should look to upcoming filings and earnings commentary for Mynaric's financial contribution and integration costs.

Apr 14, 2026 8-K

Rocket Lab 8-K Report, Executive Changes (Mar 30, 2026)

Rocket Lab Corporation (RKLB) filed an 8-K on March 30, 2026, detailing significant changes to its CEO, Sir Peter Beck's, compensation. In a move demonstrating strong commitment to shareholder value and disciplined fiscal management, Mr. Beck has voluntarily agreed to reduce his annual base salary to $1.00 or the statutory minimum, and has waived any entitlement to an annual bonus. Furthermore, Mr. Beck has forfeited all unvested Restricted Stock Units (RSUs) representing 392,155 shares. This decision will redirect capital previously allocated for his compensation towards the Company's strategic research and development (R&D) initiatives and other corporate priorities. This aligns with the company's focus on long-term appreciation of shareholder value, as opposed to short-term incentives.

Mar 30, 2026 8-K

Shareholder MattersOther Events

Rocket Lab 8-K Report, Corporate Update (Mar 17, 2026)

Rocket Lab Corporation has entered into an Equity Distribution Agreement, allowing it to sell up to $1 billion of its common stock over time through various sales agents. This agreement also enables the company to utilize forward sale agreements, a mechanism that allows for the potential sale of stock at a future date, with initial hedging activities managed by designated forward sellers. This move provides Rocket Lab with significant flexibility to access capital, potentially raising substantial funds to support its ongoing operations and growth initiatives. The agreement outlines two primary types of forward transactions: Initially Priced Forward Transactions and Collared Forward Transactions. In the former, the company will receive proceeds at a later settlement date based on an initial forward sale price. The latter involves a more complex structure where the sale price is determined by a range (floor and cap) based on initial hedging activity, with potential for prepaid amounts and eventual settlement. Investors should note that the company does not immediately receive proceeds from the initial sale of borrowed shares in forward transactions. The company's ability to execute these sales is subject to market conditions and the terms of the agreement, with sales potentially being suspended.

Mar 17, 2026 8-K

Rocket Lab 8-K Report, Shareholder Nominations (Mar 12, 2026)

Rocket Lab Corporation (RKLB) has filed an 8-K to provide notice regarding its 2026 Annual Meeting of Stockholders, scheduled for May 20, 2026. A key takeaway for investors is the deadline for submitting shareholder proposals and director nominations. Due to the date change for the annual meeting compared to the previous year, proposals intended for inclusion in the company's proxy materials under Rule 14a-8 must be received by the Company Secretary no later than March 22, 2026. This announcement is crucial for any shareholder wishing to propose resolutions or nominate candidates for the board. Investors should note that these submissions must adhere not only to SEC rules but also to Rocket Lab's Amended and Restated Bylaws. The filing specifies the address for these submissions and emphasizes that failure to comply with the outlined requirements may result in proposals being omitted from the proxy materials. While this 8-K does not disclose new financial or operational performance data, it sets important procedural deadlines for shareholder engagement.

Mar 12, 2026 8-K

Rocket Lab 8-K Report, Financial Results (Feb 26, 2026)

Rocket Lab (RKLB) reported record fourth-quarter 2025 revenue of $179.7 million, up 36% year over year from $132.4 million, and record full-year 2025 revenue of $601.8 million, up 38% from $436.2 million. Gross profit rose to $207.2 million for the year, a GAAP gross margin of 34.4% (up from 26.6% in 2024), and non-GAAP gross margin reached 39.7%. Backlog grew 73% year over year to $1.85 billion, led by the $816 million Space Development Agency contract to build 18 missile warning and tracking satellites. Management also highlighted 21 Electron and HASTE launches in 2025 with a 100% mission success rate and several acquisitions in optical payloads and precision manufacturing. Profitability remains negative. The full-year GAAP net loss widened to $198.2 million (EPS of -$0.37), and adjusted EBITDA was a loss of $101.2 million. Operating expenses grew sharply, with Q4 R&D reaching $78.8 million versus $48.3 million a year earlier, reflecting Neutron development spending. The balance sheet was substantially strengthened through an at-the-market equity program that raised roughly $1.12 billion net in 2025, lifting cash and marketable securities to about $1.10 billion at year-end. Convertible senior notes fell from $345 million to $152 million on the balance sheet. The key forward-looking item is a Neutron schedule slip: first launch is now targeted for Q4 2026 following a stage 1 tank test failure. For Q1 2026, management guided revenue of $185-200 million (midpoint implying about 57% year-over-year growth), GAAP gross margin of 34-36%, and an adjusted EBITDA loss of $21-27 million. Investors will focus on Neutron execution, the pace of backlog conversion, and whether margins continue to improve as the business scales.

Feb 26, 2026 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Jan 22, 2026)

Rocket Lab (RKLB) filed an 8-K on January 22, 2026 disclosing, via a press release dated January 21, 2026, that qualification testing of the Stage 1 tank for its Neutron medium-lift rocket ruptured during a hydrostatic pressure trial. The filing is furnished under Item 7.01 (Regulation FD, not deemed filed) and Item 8.01 (Other Events), and it contains no financial results, guidance changes, or quantified costs. Management characterizes the failure as a normal part of qualification testing, noting that the test structure and facilities sustained no significant damage and that the next Stage 1 tank is already in production. The company states that Neutron's development campaign continues while the team assesses the outcome. However, the impact on the launch schedule has not been determined. The team is still reviewing Stage 1 test data, and management intends to provide a Neutron schedule update on the Q4 2025 earnings call in February. For investors, the key takeaway is schedule risk rather than immediate financial impact. Neutron is central to Rocket Lab's medium-launch and constellation strategy, so any delay could affect the timing of revenue and the company's longer-term growth narrative. Investors should watch the February earnings call for a revised timeline, any cost or charge implications, and the results of the Stage 1 data review.

Jan 22, 2026 8-K

Earnings & ResultsLeadership ChangesExhibits & Filings

Rocket Lab 8-K Report, Regulation FD Disclosure (Dec 19, 2025)

Rocket Lab (RKLB) disclosed on December 19, 2025 that its wholly owned subsidiary, Rocket Lab USA, Inc., entered into a contract on December 17, 2025 with the U.S. Space Development Agency (SDA) to design, manufacture, and provide operations and sustainment for 18 satellites for the Tracking Layer Tranche 3 (TRKT3) program under the Proliferated Warfighter Space Architecture. The contract has a total stated value of $816 million, consisting of an $806 million base amount and options. The company describes it as its largest single contract to date. Work begins immediately, with final satellite delivery for launch expected in 2029. For investors, the award is significant because it adds a large, multi-year national security revenue stream and increases the company's total SDA awards to more than $1.3 billion, including the existing $515 million Transport Layer-Beta Tranche 2 contract. Management also states that Rocket Lab supplies payloads and components to other TRKT3 prime contractors, including its StarLite sensors, and estimates total capture value could reach about $1 billion once those subsystem opportunities are included. These subsystem figures are management estimates, not contracted amounts. Key risks include the agreement's termination-for-convenience provision, which allows either party to end the contract at any time subject to conditions, and the long delivery timeline to 2029, which leaves room for schedule and execution risk. The 8-K's options figure ($10 million) differs slightly from the press release's "up to $10.45 million," so investors should confirm the exact option value in the full contract documentation.

Dec 19, 2025 8-K

Rocket Lab 8-K Report, Financial Results (Nov 10, 2025)

Rocket Lab (RKLB) reported record third-quarter 2025 revenue of $155.1 million, up 48% year-over-year from $104.8 million, with GAAP gross margin of 37% (GAAP gross profit of $57.3 million versus $28.0 million a year earlier). Operating loss widened to $59.0 million from $51.9 million as operating expenses grew 46% to $116.3 million, driven by higher R&D (up to $70.7 million) and SG&A (up to $45.6 million), including $5.1 million of transaction costs tied to acquisitions. Net loss narrowed sharply to $18.3 million, or $0.03 per share, from $51.9 million, primarily because of a $41.1 million income tax benefit. Adjusted EBITDA was a loss of $26.3 million, compared with a loss of $30.9 million in the prior-year quarter. Balance sheet strength improved materially. Cash and cash equivalents rose to $807.9 million from $271.0 million at year-end 2024, and management states total liquidity exceeds $1 billion after the at-the-market equity program, which raised $865.5 million gross during the first nine months. Total assets grew to $2.22 billion, with goodwill and intangibles rising substantially after the Geost acquisition (up to $325 million, cash plus equity) and the Mynaric restructuring. Cash burn remains significant: net cash used in operating activities was $101.0 million for the nine months, and capital expenditures were $106.6 million, largely related to Neutron and Launch Complex 3 buildout. For Q4 2025, management guided to revenue of $170 million to $180 million, GAAP gross margin of 37% to 39%, and adjusted EBITDA loss of $23 million to $29 million, and expects to surpass its prior annual launch record and reach 20+ launches for the year. Neutron is now expected to arrive at Launch Complex 3 in Q1 2026, with first launch thereafter pending qualification testing. The 8-K also discloses that director Matt Ocko resigned from the board effective November 30, 2025, with no disagreement with the company cited.

Nov 10, 2025 8-K

Securities & ListingOther Events

Rocket Lab 8-K Report, Unregistered Securities Sale (Sep 25, 2025)

Rocket Lab Corporation has announced a significant acquisition, entering into a Stock Purchase Agreement to acquire all outstanding ordinary shares of Mynaric AG, a German-based company. This strategic move is valued at an aggregate of $75 million, with the consideration payable in either cash or Rocket Lab's common stock at the company's discretion. The deal also includes potential post-closing earnout payments of up to $75 million, contingent on Mynaric's revenue performance in 2025, 2026, and 2027, also payable in cash or stock. The acquisition, if completed, represents a substantial expansion for Rocket Lab, integrating Mynaric's business into its operations. The consideration for the transaction, including any stock issued, will be made under exemptions from registration requirements, specifically Section 4(a)(2) of the Securities Act of 1933. Rocket Lab has committed to filing a resale registration statement for any shares issued in the transaction within 30 days post-closing, providing liquidity assurances for those receiving stock. The transaction is subject to customary closing conditions and regulatory approval from the German Ministry of Foreign Affairs.

Sep 25, 2025 8-K

Leadership ChangesShareholder MattersExhibits & Filings

Rocket Lab 8-K Report, Corporate Update (Sep 15, 2025)

Rocket Lab Corporation has entered into a new At-the-Market (ATM) Equity Offering Sales Agreement with a syndicate of well-known financial institutions, allowing it to sell up to $750 million worth of its common stock. This move follows the termination of a previous ATM sales agreement. The company is not obligated to sell any shares, but this provides flexibility to raise capital opportunistically through its effective shelf registration statement. Investors should view this as a tool for potential future funding needs, rather than an immediate indication of financial distress. The termination of the prior agreement and the establishment of this new, larger facility suggest a strategic decision to maintain access to equity markets. The substantial size of the offering indicates Rocket Lab's preparedness for potential capital requirements related to its ambitious growth plans in the space sector, including launch services and satellite components. The use of multiple sales agents diversifies execution capabilities and potentially optimizes pricing.

Sep 15, 2025 8-K

Rocket Lab 8-K Report, Executive Changes (Aug 29, 2025)

Rocket Lab Corporation (RKLB) filed an 8-K on August 29, 2025, detailing key governance and stockholder decisions made during its 2025 Annual Meeting of Stockholders on August 27, 2025. A significant development is the adoption of a Senior Executive Cash Incentive Bonus Plan by the Compensation Committee, designed to incentivize leadership through performance-based bonuses tied to corporate financial and operational goals, as well as individual performance. This plan aims to align executive compensation with the company's strategic objectives and performance metrics. Additionally, the filing reports the outcomes of several stockholder proposals. Directors Jon Olson, Merline Saintil, and Alex Slusky were elected to the Board of Directors. The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2025 was ratified. Stockholders provided advisory approval for the compensation of named executive officers. However, a proposed amendment to the Amended and Restated Certificate of Incorporation of Rocket Lab USA, Inc., intended to eliminate a pass-through voting provision, did not receive the required supermajority vote for approval.

Aug 29, 2025 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Aug 12, 2025)

Rocket Lab (RKLB) reported in this 8-K, dated August 12, 2025, that its wholly-owned subsidiary Rocket Lab USA, Inc. closed its previously announced acquisition of the parent holding company of GEOST LLC, a developer of electro-optical and infrared (EO/IR) sensor systems for national security space missions. The total headline value was $275 million before closing adjustments, consisting of $125 million in cash and 3,057,588 shares of common stock, plus an additional earnout of up to $50 million in cash tied to future GEOST revenue targets. The deal was first announced on May 27, 2025, and the filing does not disclose GEOST's revenue, earnings, or the purchase price allocation, so investors cannot yet assess the acquisition's financial contribution from this document. Strategically, the acquisition adds payload capability to Rocket Lab's existing launch and spacecraft businesses. Management positions the company as a prime contractor for defense programs such as the Golden Dome concept and the Space Development Agency's Proliferated Warfighter Space Architecture, with GEOST's missile warning, tracking, ISR, and space domain awareness payloads as the new offering. GEOST is described as having over 100 employees and operations in Arizona and Virginia, and the company expects to use Rocket Lab's manufacturing resources to scale high-volume EO/IR production. From a capital perspective, the stock consideration is modest, roughly 3.06 million shares, and the company also filed a prospectus supplement registering the resale of those shares by the selling stockholder under an existing S-3ASR shelf. This creates a potential source of incremental supply in the market. Investors should weigh the cash outlay and possible earnout against integration execution risk and the eventual disclosure of GEOST's financial performance.

Aug 12, 2025 8-K

Shareholder MattersOther Events

Rocket Lab 8-K Report, Financial Results (Aug 7, 2025)

Rocket Lab reported record second-quarter 2025 revenue of $144.5 million, up 36% year over year from $106.3 million. Gross margin expanded sharply: GAAP gross margin rose to about 32.1% from 25.6% a year earlier, and non-GAAP gross margin reached 36.9% versus 30.7%. Growth was driven by product revenue of $92.7 million and service revenue of $51.8 million, with five successful Electron launches in the quarter. Profitability remains elusive. The operating loss widened to $59.6 million from $43.3 million, as R&D (up about 66% to $66.1 million) and SG&A grew faster than gross profit. Net loss was $66.4 million, or $0.13 per share, and adjusted EBITDA was a loss of $27.6 million. The balance sheet strengthened materially during the first half, supported by about $397 million in gross proceeds from an at-the-market equity offering. Cash and equivalents reached $564 million, and including marketable securities, total liquidity was roughly $749 million. Management is guiding to third-quarter revenue of $145 million to $155 million, GAAP gross margin of 35% to 37%, and an adjusted EBITDA loss of $21 million to $23 million, which implies continued operating losses but some improvement in margin trajectory. Strategically, the company is pursuing growth beyond launch. It is acquiring Geost for $275 million in a cash-plus-equity deal, with a potential time-based revenue earnout of up to $50 million, to create a Payloads business unit aimed at defense satellite contracts. It also moved into production on an $515 million constellation build of 18 spacecraft for the Space Development Agency's Tranche 2 Transport Layer. Neutron's Launch Complex 3 is expected to open in Q3 2025. Investors should weigh strong top-line momentum and margin progress against widening losses, heavy R&D spending, and dilution from equity issuance and the pending acquisition.

Aug 7, 2025 8-K

Rocket Lab 8-K Report, Shareholder Nominations (Jun 9, 2025)

Rocket Lab Corporation has filed an 8-K detailing important dates for its 2025 annual meeting of stockholders. The company anticipates holding the meeting on August 27, 2025. Due to a significant shift in the meeting date compared to the previous year's meeting, Rocket Lab has established specific deadlines for stockholders wishing to submit proposals for inclusion in the proxy materials or to nominate directors. Investors looking to submit proposals for the 2025 Annual Meeting under Rule 14a-8 must ensure their proposals are received by the Company's Secretary by June 19, 2025. Similarly, any stockholder wishing to nominate a director or propose other business for consideration at the meeting, as outlined in the Company's bylaws, must also provide timely notice by the same June 19, 2025 deadline. Failure to meet these deadlines, along with compliance with all other bylaw and SEC requirements, may result in proposals or nominations not being considered at the meeting.

Jun 9, 2025 8-K

Material AgreementsSecurities & ListingRegulation FD+1

Rocket Lab 8-K Report, Material Agreement (May 27, 2025)

Rocket Lab Corporation (Nasdaq: RKLB) has agreed to acquire LightRidge Interco, the parent holding company of GEOST LLC, a Tucson, Arizona-based producer of electro-optical and infrared (EO/IR) payloads for U.S. national security satellites. Under the Stock Purchase Agreement signed May 22, 2025, the total consideration is $275 million: up to approximately $125 million in cash and up to approximately $150 million in Rocket Lab common stock, subject to customary closing adjustments. An additional earnout of up to $50 million in cash is tied to GEOST revenue targets for 2026 and 2027. The deal marks Rocket Lab's formal entry into the satellite payload segment, which management frames as a move toward vertically integrated, end-to-end national security space solutions. The transaction is subject to customary conditions, including expiration or termination of the HSR Act waiting period, and is expected to close in the second half of 2025. The stock consideration will be valued based on the closing price on the Nasdaq Capital Market the trading day before closing, subject to a base price floor condition. Rocket Lab has agreed to file a resale registration statement covering the shares issued in the deal, which could add selling pressure once the shares become registrable. The stock portion is being issued in a private placement under Section 4(a)(2) and/or Regulation D. The filing also discloses a holding company reorganization completed May 23, 2025, under which Rocket Lab Corporation, a Delaware corporation, became the successor issuer to Rocket Lab USA, Inc. The full Purchase Agreement will be filed as an exhibit to the next Form 10-Q, so investors should review it then for the complete terms, including adjustment mechanics and the earnout structure. Financial terms such as GEOST's revenue, earnings, and margins were not disclosed in this filing.

May 27, 2025 8-K

Earnings & ResultsOther EventsExhibits & Filings

Rocket Lab 8-K Report, Financial Results (May 8, 2025)

Rocket Lab USA (RKLB) reported first-quarter 2025 revenue of $122.6 million, up 32% year over year from $92.8 million and at the top end of its guidance. Product revenue rose to $80.8 million from $54.1 million, while service revenue grew more modestly to $41.8 million from $38.6 million. Profitability weakened: GAAP gross margin was about 28.8% (up from 26.1%), but operating expenses rose 40% to $94.4 million, driven by research and development (up 43%) and selling, general and administrative costs (up 37%). The operating loss widened to $59.2 million, and the net loss was $60.6 million, or $0.12 per share, versus $44.3 million a year earlier. Adjusted EBITDA was a loss of $30.0 million. Operating cash flow was negative $54.2 million and capital expenditures were $28.7 million, implying free cash flow of roughly negative $83 million. The company raised about $92.8 million in gross proceeds through an at-the-market equity program and a $25 million secured term loan. Cash, cash equivalents and marketable securities totaled roughly $512 million at quarter-end, based on the balance sheet. For Q2 2025, management guided to revenue of $130 million to $140 million, GAAP gross margin of 30% to 32%, and an adjusted EBITDA loss of $28 million to $30 million. Stock-based compensation is expected at $13 million to $14 million. The guidance implies continued revenue growth alongside sustained operating losses. Strategically, the company announced a holding company reorganization, expected to be effective by June 1, 2025, in which Rocket Lab Corporation would become the new public parent. Shares would convert one-for-one, the stock would keep trading as RKLB on Nasdaq, and the reorganization is intended to be tax-free to shareholders and does not require a stockholder vote. The company also disclosed its pending acquisition of Mynaric, which would extend its presence into Europe, and its Neutron rocket's on-ramp to the Space Force's NSSL Phase 3 Lane 1 program. For investors, the central tension is strong top-line growth and expanding government and defense demand against rising operating losses, heavy investment in Neutron and new business lines, and continued reliance on capital markets to fund the cash burn. Execution on Neutron, margin improvement, and the Mynaric integration will be key items to monitor.

May 8, 2025 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Mar 11, 2025)

On March 11, 2025, Rocket Lab USA, Inc. (Nasdaq: RKLB) entered into an ATM (at-the-market) Equity Offering Sales Agreement with BofA Securities, Cantor Fitzgerald & Co., Stifel, Nicolaus & Company, and TD Securities (USA) LLC. The agreement allows Rocket Lab to sell up to $500 million of its common stock from time to time through these sales agents, acting either as agents or as principal. The offering is made under an automatically effective Form S-3 shelf registration and a related prospectus supplement, both filed the same day. Rocket Lab is under no obligation to sell any shares, and either party may terminate the agreement at any time on written notice. The company stated that it intends to use any net proceeds to fund future growth, including potential acquisitions such as its announced intent to acquire laser communications provider Mynaric, as well as for general corporate and working capital purposes. Because the program is discretionary and the timing and size of sales will depend on factors set by the company, the filing does not commit Rocket Lab to any specific issuance. Investors should note that an ATM program creates the possibility of future dilution to existing shareholders, though the actual amount depends on how much stock is sold and at what prices. The filing is primarily a financing-capacity disclosure rather than a report of completed transactions. No shares had been sold as of the filing, and the 8-K does not disclose pricing, share counts, or the financial terms of the Mynaric acquisition. Investors should review the prospectus supplement and the company's Form 10-K for the year ended December 31, 2024 for risk factors and more complete information.

Mar 11, 2025 8-K

Shareholder MattersCorporate ChangesExhibits & Filings

Rocket Lab 8-K Report, Financial Results (Feb 27, 2025)

Rocket Lab reported record full-year 2024 revenue of $436.2 million, up 78% from $244.6 million in 2023, and record fourth-quarter revenue of $132.4 million, up 121% year over year from $60.0 million. Growth was driven by both segments: service revenue rose to $48.4 million in Q4 from $12.1 million, and product revenue rose to $84.0 million from $47.9 million. Profitability improved but remains negative. Q4 GAAP gross margin was about 27.8% (non-GAAP 34.0%), and GAAP operating loss narrowed to $51.5 million from $47.9 million, though it widened slightly year over year. Full-year net loss was $190.2 million, or $0.38 per share, and Adjusted EBITDA loss improved to $96.9 million from $90.9 million. The balance sheet shows roughly $480 million in cash and marketable securities at year-end, including $271.0 million in cash, $147.9 million in current marketable securities and $60.7 million in non-current marketable securities. Against this, the company carries $345.4 million in net convertible senior notes issued in 2024. Operating cash burn was $48.9 million for the year, and capital expenditures were $67.1 million. Management guided Q1 2025 revenue to $117 million to $123 million, which implies a sequential decline from Q4, with Adjusted EBITDA loss of $33 million to $35 million. Management also highlighted more than $450 million in new contracts, 16 Electron launches in 2024, and a planned second-half 2025 debut of the Neutron rocket. For investors, the key question is whether revenue momentum and contract backlog can translate into margin expansion and sustained cash generation as the company scales. The Q1 guidance decline, continued operating losses and the Neutron debut timing are the main near-term watch items. This filing is furnished under Item 2.02 and is not deemed filed for Section 18 liability purposes.

Feb 27, 2025 8-K

Rocket Lab 8-K Report, Rights Modification (Jan 10, 2025)

Rocket Lab USA, Inc. (RKLB) announced the consummation of a Preferred Stock Exchange on January 7, 2025, where 50,951,250 shares of common stock held by The Equatorial Trust, a family trust established by founder Sir Peter Beck, were exchanged for an equal number of shares of Series A Convertible Participating Preferred Stock. This exchange, previously disclosed, has now been finalized with the filing of the Certificate of Designation. The preferred stock carries specific conversion rights and automatic conversion triggers, including events related to Sir Peter Beck's role within the company and his beneficial ownership levels. It also grants the holders, voting as a separate class, the right to elect at least one director to the Company's Board and additional directors if the Board size increases significantly. The preferred stock has a nominal liquidation preference but participates alongside common stockholders in residual assets.

Jan 10, 2025 8-K

Leadership ChangesMaterial AgreementsSecurities & Listing+1

Rocket Lab 8-K Report, Material Agreement (Dec 5, 2024)

Rocket Lab Corp (RKLB) filed an 8-K on December 5, 2024, detailing a material definitive agreement concerning an exchange of shares. The company entered into an Exchange Agreement with The Equatorial Trust, whereby the Trust will exchange 50,951,250 shares of RKLB Common Stock, beneficially owned by Sir Peter Beck, for an equivalent number of shares of a new series of Preferred Stock. This transaction is expected to close in early 2025 and is subject to customary closing conditions, including Hart-Scott-Rodino Act waiting periods. The newly issued Preferred Stock carries significant rights and features designed to align with Sir Peter Beck's continued leadership and influence within the company. Key among these is the conversion feature, which allows the Preferred Stock to convert into Common Stock under various circumstances, including Sir Peter's departure from executive roles or upon certain ownership thresholds being met. Furthermore, holders of the Preferred Stock will have the right to designate at least one director to the RKLB Board, with Sir Peter Beck slated to be the initial Preferred Stock Director. This exchange, alongside an amended and restated employment agreement for Sir Peter Beck, underscores a strategic effort to secure leadership continuity and executive compensation while introducing a structured mechanism for potential future equity shifts.

Dec 5, 2024 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Nov 29, 2024)

Rocket Lab USA (RKLB) disclosed in this Form 8-K, filed November 29, 2024, that its wholly-owned subsidiary SolAero Technologies Corp. entered into a Direct Funding Agreement with the U.S. Department of Commerce on November 22, 2024. Under the CHIPS and Science Act, SolAero may receive up to $23.9 million in funding to expand compound semiconductor manufacturing at its Albuquerque, New Mexico facility, which produces space-grade solar cells. Funds will be disbursed against a milestone schedule tied to project phases. The press release furnished as Exhibit 99.1 (dated November 25, 2024) describes this as finalizing an award that followed a preliminary term sheet earlier in 2024. The funding is not free capital. Rocket Lab guaranteed SolAero's obligations under the Funding Agreement and committed to contribute at least $32 million of equity to SolAero over time so the project can be completed. The filing also imposes operating restrictions on both the company and SolAero: SolAero cannot enter certain partnerships, joint ventures, or mergers, acquire certain equity interests, dispose of certain property, or make certain capital contributions without the Department's prior written consent. Absent exceptions, the parent company also cannot conduct stock buybacks or pay dividends without that consent. Assets acquired or improved with Award Funds must be held in trust for the Department. For investors, the event is modest in size relative to Rocket Lab's overall business, but it carries a meaningful commitment: the $32 million equity contribution is larger than the award itself, and the restrictions constrain capital allocation and corporate flexibility for the duration of the project. The filing is a Regulation FD disclosure and a material-agreement disclosure rather than a change in financial results. The main benefits are expanded capacity in one of only two U.S. producers of radiation-hardened space-grade solar cells, supporting national security and commercial satellite demand.

Nov 29, 2024 8-K

Leadership ChangesRegulation FDExhibits & Filings

Rocket Lab 8-K Report, Financial Results (Nov 12, 2024)

Rocket Lab USA (RKLB) reported third-quarter 2024 results on November 12, 2024 (furnished under Item 2.02 with press release Exhibit 99.1). Revenue rose 55% year-over-year to $104.8 million, up from $67.7 million, and nine-month revenue reached $303.8 million. Gross profit was $28.0 million (26.7% GAAP gross margin), but the company remained unprofitable: GAAP operating loss widened to $51.9 million and net loss was $51.9 million, or $(0.10) per share. Adjusted EBITDA was a loss of $30.9 million, compared with a $15.5 million loss a year earlier. Operating expenses rose sharply as R&D nearly doubled to $47.7 million, reflecting Neutron development and Archimedes engine testing. Balance sheet liquidity improved materially during the period. Cash and cash equivalents rose to $292.5 million, and total cash plus marketable securities (current and non-current) was roughly $504 million, versus about $324 million at year-end 2023. The company issued $355 million of convertible senior notes and used part of the proceeds to repay the $48.9 million Trinity Loan and purchase capped calls. Total liabilities increased to $733 million, largely due to the convertible notes, and stockholders' equity fell to $420 million from $555 million as the accumulated deficit grew. Operating cash burn was $46.5 million over nine months, and capital expenditures were $45.5 million. Management highlighted a record backlog of $1.05 billion, 12 Electron launches year-to-date (a company record), $55 million in new Electron contracts, and a Neutron launch services agreement with a confidential constellation customer. Guidance for Q4 2024 calls for revenue of $125 million to $135 million, GAAP gross margin of 26% to 28%, and adjusted EBITDA loss of $27 million to $29 million. Investors should weigh strong top-line growth and backlog against a persistent operating loss, rising R&D spending, and dilution risk from the convertible notes.

Nov 12, 2024 8-K

Leadership Changes

Rocket Lab 8-K Report, Executive Changes (Sep 16, 2024)

This 8-K filing from Rocket Lab USA, Inc. (RKLB) reports the immediate resignation of Michael Griffin from its Board of Directors, effective September 12, 2024. Mr. Griffin's departure is stated to be for retirement and is not attributed to any disagreements with the company regarding its operations, policies, or practices. The company expressed gratitude for his contributions and insights during his tenure. While the departure of a board member is noteworthy, the filing explicitly states it's for retirement and amicable. Investors should focus on Rocket Lab's ongoing operational performance and strategic initiatives, as this filing does not indicate any material disruption to the company's business or governance structure. Further details on board composition and future appointments, if any, will be key areas to monitor.

Sep 16, 2024 8-K

Rocket Lab 8-K Report, Executive Changes (Sep 10, 2024)

Rocket Lab USA, Inc. (Nasdaq: RKLB) filed an 8-K on September 10, 2024 announcing the appointment of Frank Klein as Chief Operations Officer, effective September 16, 2024. Klein brings more than 30 years of manufacturing and operations experience, most recently as COO of Rivian Automotive (2022–2024), where he oversaw 9,000+ employees, and previously as President of Magna Steyr AG and a 27-year veteran of Daimler AG. His mandate is to scale production of spacecraft, launch vehicles, and spacecraft components to meet a backlog of more than $1 billion in orders. The filing's compensation package is the key item for investors to note. Klein receives a $400,000 base salary, a discretionary annual bonus of up to 70% of base, a $100,000 sign-on bonus, and 1,300,000 restricted stock units vesting over four years. The RSU grant is the most material element, and its dilution impact depends on the company's share count, which is not disclosed in this filing. He is also covered under the Tier 2 Executive Severance Plan and will enter the company's standard indemnification agreement. The filing reports no related-party transactions involving Klein above $120,000. The appointment is a leadership addition rather than a financial event, and the filing contains no financial results or guidance. CEO Sir Peter Beck tied the hire to Electron launch cadence growth, the operationalization of Neutron, and a path to profitability for the satellite and space systems divisions. Investors should view the appointment as a signal of intent to professionalize manufacturing at scale, with execution against those goals as the real test over time.

Sep 10, 2024 8-K

Rocket Lab 8-K Report, Executive Changes (Aug 23, 2024)

Rocket Lab USA, Inc. (Nasdaq: RKLB) filed this Form 8-K to disclose a board change: on August 21, 2024, the Board expanded from eight to nine directors and appointed Kenneth Possenriede as a Class III director to fill the newly created vacancy, with a term expiring at the 2027 annual meeting. The Company has determined he is independent under Nasdaq listing standards, and he was also named to the Audit Committee. Investors should note the appointment strengthens the Board's financial oversight, since Possenriede is a former Lockheed Martin EVP and CFO (2019 to 2021) with a background in treasury, capital markets, and program finance. The filing does not disclose any financial results, guidance, or operating metrics, so it is a governance event rather than a performance catalyst. Compensation terms follow the Company's standard non-employee director policy. He receives a prorated 2024 cash retainer, a one-time initial RSU grant valued at $360,000 vesting in three equal annual installments, and an annual RSU grant valued at $180,000 (or a pro-rata portion at the next annual meeting). All equity awards accelerate in full upon a sale of the Company. He will also enter into the Company's standard indemnification agreement. The filing reports no related-party transactions over $120,000 involving him and no arrangements under which he was selected. The accompanying press release (Exhibit 99.1, dated August 22, 2024) emphasizes his aerospace and defense experience and Rocket Lab's positioning as an end-to-end space company, citing Electron, the space systems business, and Neutron development. These are company characterizations rather than audited data. Overall, the filing is a routine director appointment with modest dilution implications limited to the standard equity grants, and its main significance is the added financial expertise on the Board and Audit Committee.

Aug 23, 2024 8-K

Rocket Lab 8-K Report, Financial Results (Aug 8, 2024)

Rocket Lab reported record second-quarter 2024 revenue of $106.3 million, up 71% from $62.0 million a year earlier, driven by growth in both Launch Services and Space Systems. Net loss narrowed to $41.6 million from $45.9 million, and Adjusted EBITDA loss widened slightly to $21.2 million from $20.2 million. GAAP gross margin improved to about 25.6% from about 23.5%, and non-GAAP gross margin was 30.7%, down from 31.8% a year earlier. Operating expenses rose to $70.4 million, led by a 29% increase in research and development spending tied to the Neutron program. The balance sheet strengthened materially during the period. Rocket Lab issued $355 million of convertible senior notes due to fund operations and repaid $45.8 million under its Trinity loan. Cash, cash equivalents and marketable securities totaled roughly $543 million at June 30, 2024, up from about $324 million at year-end 2023, and contract liabilities grew to $184 million, indicating strong forward bookings. Management also reported more than $720 million in spacecraft under contract and 17 new launch contracts signed year-to-date. The third-quarter guidance is the key point for investors. Revenue of $100 million to $105 million implies a sequential decline from Q2, and the company expects Adjusted EBITDA loss of $31 million to $33 million, wider than Q2's $21 million loss, with GAAP operating expenses of $80 million to $82 million. Investors will be focused on Neutron development milestones, the timing of the first Neutron flight, and whether the company can reach profitability as its Launch Services and Space Systems revenue scales.

Aug 8, 2024 8-K

Shareholder Matters

Rocket Lab 8-K Report, Shareholder Vote Results (Jun 14, 2024)

Rocket Lab USA, Inc. (RKLB) filed an 8-K on June 14, 2024, detailing the results of its 2024 Annual Meeting of Stockholders held on June 12, 2024. The meeting saw strong participation with over 71% of outstanding shares represented. Key outcomes included the election of two Class III directors, Lt. Gen. Nina M. Armagno (Ret.) and Peter Beck, to serve three-year terms. Both directors received substantial support from stockholders, indicating confidence in their leadership and the company's direction. Furthermore, the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was overwhelmingly ratified by the stockholders. Finally, the compensation of the company's named executive officers was approved on an advisory basis, with a significant majority of votes cast in favor. These outcomes reflect general stockholder approval of the company's governance and executive compensation practices.

Jun 14, 2024 8-K

Rocket Lab 8-K Report, Financial Results (May 6, 2024)

Rocket Lab reported first-quarter 2024 revenue of $92.8 million, up 69% year over year from $54.9 million and up roughly 55% sequentially per the company's headline. Gross profit rose to $24.2 million (GAAP gross margin about 26%, non-GAAP gross margin 31.7%, versus 17.9% a year earlier). Operating loss narrowed to $43.1 million from $46.0 million, and net loss was $44.3 million, or $0.09 per share, compared with $45.6 million a year earlier. Adjusted EBITDA improved to a loss of $21.7 million from $26.2 million. Revenue growth and margin expansion were the main positives, though the company remains unprofitable. The balance sheet changed materially. Rocket Lab issued $355 million of convertible senior notes, bought $43.2 million of capped calls, and repaid $43.2 million of its Trinity loan. Cash, cash equivalents and marketable securities total about $561 million, up from roughly $325 million at year-end 2023. Total liabilities rose to $703 million from $387 million, driven mainly by the $344 million net carrying value of the notes. Operating cash burn was small in the quarter ($2.6 million used in operations), but capital expenditures of $19.2 million continue to rise as the company builds out Neutron. Management cited a backlog above $1 billion and guided second-quarter 2024 revenue to $105 million to $110 million, with adjusted EBITDA loss of $23 million to $25 million. The company also pushed its Neutron medium-lift rocket's first launch target to no earlier than mid-2025, citing the new schedule after the first complete Archimedes engine was assembled. Investors should weigh the strong growth and funded balance sheet against continued losses, the convertible debt, and execution risk on Neutron and the $515 million Space Development Agency program.

May 6, 2024 8-K

Rocket Lab 8-K Report, Executive Changes (Apr 18, 2024)

Rocket Lab USA, Inc. (Nasdaq: RKLB) filed a Form 8-K on April 18, 2024 to disclose a board change. Director Sven Strohband, who has served on the Board since 2013, notified the company on April 12, 2024 that he will not stand for re-election at the 2024 Annual Meeting of Stockholders, scheduled for June 12, 2024. He will remain a director until that meeting. The company stated that his decision was not the result of any dispute or disagreement regarding its operations, policies, or practices. Strohband is a Managing Director at Khosla Ventures and was an early backer of Rocket Lab, leading its Series A round. The Board and CEO Peter Beck thanked him for his contributions through funding rounds, the first Electron launch, the Nasdaq listing, and the expansion into space systems. Beck said the Board remains "stacked with formidable talent and experience." For investors, this is a routine governance transition with no reported financial impact. The filing contains no financial statements, guidance, or new contracts. The main items to monitor are the composition of the Board after the June 2024 annual meeting and any further nominee announcements, along with the company's ongoing operational updates.

Apr 18, 2024 8-K

Material AgreementsFinancial EventsSecurities & Listing+2

Rocket Lab 8-K Report, Financial Results (Feb 27, 2024)

Rocket Lab reported fourth quarter and full-year 2023 results that showed continued revenue growth and improving gross margins, but widening losses as it funds the Neutron rocket program. Full-year revenue rose 16% to $244.6 million from $211.0 million, and Q4 revenue rose 16% to $60.0 million from $51.8 million. GAAP gross margin expanded 12.0 percentage points to 21.0% for the year, and non-GAAP gross margin expanded 6.9 points to 28.1%. Profitability moved the other way. Net loss widened to $182.6 million from $135.9 million, and Adjusted EBITDA loss deepened to $90.9 million from $38.5 million, driven by a sharp increase in R&D spending to $119.1 million from $65.2 million, mainly for Neutron. The quarter's most important development was the Space Development Agency award of up to $515 million, under which Rocket Lab will act as prime contractor for the first time to build and operate 18 satellites for the Tranche 2 Transport Layer-Beta. Operationally, the company flew a record ten Electron missions in 2023 and signed a record 25 new Electron and HASTE launch contracts. Liquidity fell over the year. Cash and equivalents dropped to $162.5 million from $242.5 million, and operating cash burn was $98.9 million. Total cash and marketable securities were approximately $324 million at year-end, before the $355 million convertible notes offering completed in early 2024. Management guided Q1 2024 revenue to $92 million to $98 million, which implies sequential growth above 50% from Q4 2023. Guidance also calls for a GAAP gross margin of 24% to 26% and an Adjusted EBITDA loss of $28 million to $30 million. Investors will want to watch whether the guided margin improvement holds, whether Neutron hot-fire and development milestones stay on schedule, and how the new convertible notes are deployed toward M&A and growth investment, since the company's cash burn remains substantial. This filing is furnished under Item 2.02 and is not deemed filed under Section 18 of the Exchange Act.

Feb 27, 2024 8-K

Rocket Lab 8-K Report, Material Agreement (Feb 7, 2024)

On February 6, 2024, Rocket Lab USA issued $355.0 million of 4.250% Convertible Senior Notes due February 1, 2029, after upsizing the offering from $300.0 million and fully exercising the $55.0 million option granted to the initial purchasers. The notes are senior, unsecured obligations. They are effectively subordinated to the company's secured debt, including its equipment financing agreement, and structurally subordinated to all liabilities of its subsidiaries. Interest is payable semi-annually beginning August 1, 2024. The initial conversion price is approximately $5.13 per share (195.1029 shares per $1,000 principal), and conversion may be settled in cash, shares, or a combination at the company's election. Holders can convert before November 1, 2028 only upon certain triggering events, and freely thereafter. The company entered into capped call transactions at a cost of about $43.2 million to offset dilution from conversions up to a cap price, which management says lifts the effective conversion price to $8.04. Per the press release, net proceeds are about $300.3 million after capped call costs and roughly $11.5 million of underwriting and offering expenses. About $40 million is earmarked to repay part of the equipment financing borrowings, with the remainder for working capital and general corporate purposes, including potential acquisitions. Management cited oversubscription and the comparatively low cost of capital and reduced dilution relative to equity issuance as rationale. Investors should weigh the near-term balance sheet benefit against the coupon of roughly $15 million per year, the dilution risk if the stock trades well above the cap price, and the limited call protection before February 2027. The filing also specifies that the company may not redeem the notes before February 1, 2027. After that date, redemption requires a share price above 130% of the conversion price (about $6.67) for specified trading periods, plus liquidity conditions. Holders may require repurchase at par plus accrued interest upon a fundamental change, and standard events of default apply, including a cross-default threshold of $50 million on other indebtedness. Notes were sold under Rule 144A, and any conversion shares are to be issued under Section 3(a)(9), with an initial maximum of about 88.3 million shares at the make-whole maximum conversion rate.

Feb 7, 2024 8-K

Rocket Lab 8-K Report, Corporate Update (Feb 2, 2024)

On February 1, 2024, Rocket Lab USA (Nasdaq: RKLB) priced an upsized private offering of $300.0 million of 4.250% convertible senior notes due February 1, 2029, up from the $275.0 million initially announced on January 31. The initial purchasers also received a 13-day option to buy up to an additional $55.0 million of notes. The offering was expected to close on February 6, 2024. Estimated net proceeds are about $290.2 million, or about $343.5 million if the option is exercised in full. The notes are senior, unsecured obligations with an initial conversion rate of 195.1029 shares per $1,000 principal, or about $5.13 per share. That price is a roughly 27.5% premium to the $4.02 closing price on February 1, 2024. Rocket Lab may settle conversions in cash, shares, or a combination. The company also entered into capped call transactions with a cap price of $8.04 per share, a 100% premium to the reference price, to reduce potential dilution. About $36.5 million of proceeds will fund the capped calls. Roughly $40 million will repay part of the borrowings under its equipment financing agreement, and the remainder goes to working capital and general corporate purposes, including potential acquisitions. For investors, the transaction adds meaningful liquidity and refinances some higher-cost equipment debt, while the convertible structure defers equity dilution until the stock trades above about $5.13, with the capped calls offsetting dilution up to $8.04. The filing does not disclose the company's cash position, operating results, or the fiscal 2023 financial statements, so the notes should be evaluated alongside those disclosures and the risks in the Form 10-K. Note also that the January 31 release referenced a $41.25 million option, which was superseded by the $55.0 million option in the February 1 pricing release.

Feb 2, 2024 8-K

Regulation FDExhibits & Filings

Rocket Lab 8-K Report, Financial Results (Jan 31, 2024)

Rocket Lab USA (RKLB) furnished an 8-K on January 31, 2024 with preliminary, unaudited estimates for its fourth quarter ended December 31, 2023. Management estimates Q4 revenue of $59.0 million to $61.0 million, up roughly 14% to 18% from $51.8 million a year earlier. Growth came from Space Systems, which is estimated at $50.5 million to $52.5 million versus $39.7 million, while Launch Services fell to an estimated $8.5 million from $12.0 million. Management attributed the launch shortfall to an Electron mission postponed from late 2023 into 2024, and said the delay is not expected to affect future results. Profitability weakened on a year-over-year basis. GAAP gross margin is estimated at 24.8% to 26.8%, up from 3.5%, and non-GAAP gross margin at 31.4% to 33.2%, up from 14.5%. However, GAAP operating expenses are estimated to rise to $62.5 million to $64.5 million from $39.1 million, and the net loss is estimated at $49.0 million to $52.5 million, compared with $37.2 million. Adjusted EBITDA loss is estimated at $28.0 million to $30.0 million, versus $14.5 million a year earlier. Investors should treat these figures cautiously: they are preliminary, unaudited, not reviewed by Deloitte, and subject to change. Full fourth-quarter and fiscal 2023 results are scheduled for February 27, 2024. CEO Peter Beck highlighted the return of Electron to service, the $515 million Space Development Agency Tranche 2 Beta award (described as the company's largest contract to date), a record backlog, more scheduled launches in 2024 than in any prior year, and progress on the Neutron medium-lift rocket. The filing does not provide full-year guidance or audited financial statements.

Jan 31, 2024 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Jan 8, 2024)

Rocket Lab USA (Nasdaq: RKLB) announced on January 8, 2024 that it has been selected by the Space Development Agency (SDA) as prime contractor to design and build 18 Tranche 2 Transport Layer-Beta (T2TL-Beta) data transport satellites under a $515 million firm-fixed-price agreement. The contract comprises a $489 million base value plus $26 million in incentives and options, and will be executed by Rocket Lab National Security (RLNS), a wholly owned subsidiary. This was the previously disclosed agreement from December 21, 2023, and this 8-K furnishes the related press release under Regulation FD rather than reporting new financial results. For investors, the significance lies in the company's move from primarily a launch provider toward a satellite prime contractor for the U.S. defense market. Management emphasized vertical integration, with in-house production of solar panels, structures, star trackers, reaction wheels, radios, flight software, avionics, and launch dispensers, which it argues gives greater control over cost, schedule, and quality. The satellites are scheduled for launch in 2027, so meaningful revenue recognition will extend over a multi-year period. The filing does not disclose revenue timing, margin expectations, or the impact on backlog beyond the general statement of a backlog of more than 40 satellites in development and production. The filing is a Regulation FD disclosure and does not include audited financial statements or updated guidance. Investors should note the forward-looking nature of the announcement, including execution risk on a fixed-price contract, which places cost overrun risk on the company, and the typical dependence of defense programs on government funding and schedule. A conference call was held the same day to discuss the contract in more detail.

Jan 8, 2024 8-K

Material AgreementsFinancial EventsSecurities & Listing

Rocket Lab 8-K Report, Material Agreement (Jan 4, 2024)

Rocket Lab USA, Inc. (RKLB) has entered into a Master Equipment Financing Agreement with Trinity Capital, Inc. for up to $120 million in equipment financing. This agreement allows for an initial draw of $70 million on the effective date, with an additional $40 million draw also on the effective date, both payable over 60 months. The remaining $30 million and $20 million tranches can be drawn at the company's option over the next 18 months and by June 30, 2025, respectively, subject to certain conditions. Importantly, a portion of the initial draws was used to pay off all outstanding obligations under its previous secured term loan with Hercules Capital, Inc., releasing associated liens. This strategic move repositions RKLB's debt structure, potentially offering more favorable terms and freeing up collateral. Additionally, in connection with this financing, Rocket Lab issued a warrant to Trinity Capital to purchase up to 728,835 shares of common stock at an exercise price of $4.87 per share, exercisable until December 29, 2027.

Jan 4, 2024 8-K

Other Events

Rocket Lab 8-K Report, Corporate Update (Dec 21, 2023)

Rocket Lab USA, Inc. announced a significant contract win on December 21, 2023, through its subsidiary Rocket Lab National Security. The agreement with a United States government customer is valued at $515 million, comprising a base amount of $489 million and $26 million in incentives and options. This substantial contract involves the design, manufacturing, delivery, and operation of 18 space vehicles, underscoring Rocket Lab's growing capabilities in national security space missions. The scope of work is extensive, with deliveries scheduled for 2027 and operations extending through 2030, including an option to prolong operations until 2033. This long-term commitment highlights the government's confidence in Rocket Lab's technology and services. While the agreement includes standard termination clauses, it also allows for termination for convenience by either party under specified conditions, a common feature in government contracts.

Dec 21, 2023 8-K

Earnings & ResultsRegulation FDExhibits & Filings

Rocket Lab 8-K Report, Financial Results (Nov 8, 2023)

Rocket Lab (RKLB) reported third-quarter 2023 results on November 8, 2023, with revenue of $67.7 million, up from $63.1 million a year earlier, and a GAAP net loss of $40.6 million, or $(0.08) per share. Gross profit rose to $15.0 million (22.1% GAAP gross margin) from $8.5 million, while GAAP operating loss widened to $38.9 million from $32.0 million as R&D spending climbed to $26.6 million. Adjusted EBITDA was a loss of $15.5 million. The company ended the quarter with roughly $288 million in cash and marketable securities (cash of $140.9 million plus $147.5 million current and $82.0 million non-current marketable securities), though current borrowings of $105.1 million, largely the maturing long-term debt, now sit in current liabilities and warrant the watch on liquidity. The filing is dominated by the Electron anomaly that grounded the rocket after the September 19, 2023 failure. Management attributes the loss to an electrical arc in the high-voltage power supply feeding the Rutherford engine motor controllers, triggered by a rare combination of conditions, and has implemented enhanced ground testing and a pressurized battery frame section. Return to flight is targeted for a launch window opening November 28, 2023, for iQPS, and the company expects to formally close its investigation in the coming weeks. Guidance calls for Q4 2023 revenue of $65 million to $69 million and Q1 2024 revenue of $95 million to $105 million, a step-up that depends heavily on Electron resuming flights and on Launch Services revenue growing to $30 million to $37 million. Investors should weigh the strong manifest and defense-related HASTE bookings against near-term execution risk: the Q4 guide implies only modest growth, the Q1 2024 range relies on a successful return to flight, and the Neutron development program continues to consume substantial R&D spending. Because this 8-K furnishes the results and guidance under Items 2.02 and 7.01, the information is not deemed filed under Section 18 of the Exchange Act.

Nov 8, 2023 8-K

Rocket Lab 8-K Report, Executive Changes (Nov 1, 2023)

Rocket Lab USA (Nasdaq: RKLB) filed this Form 8-K to report that its Board of Directors increased in size from eight to nine members on October 30, 2023, and appointed retired U.S. Space Force Lt. Gen. Nina M. Armagno as a Class III director to fill the new seat. Her initial term runs until the 2024 annual meeting of stockholders. The Company has determined she is independent under Nasdaq listing standards, and she is expected to join the Board's Government Security Committee. The filing contains no financial results, guidance, or operational updates, so its investor significance is mainly governance and strategic positioning. The appointment strengthens the Board's expertise in national security and space operations, which is relevant to Rocket Lab's growing government and defense business. Armagno's background includes serving as Director of Staff at U.S. Space Force Headquarters, Director of Plans and Policy at U.S. Strategic Command, and command roles in Space Force units. CEO Peter Beck said her experience will help the Company as it scales its launch and space systems businesses. Armagno retired from active duty in July 2023. Her compensation follows the Company's standard non-employee director policy. It includes a prorated 2023 cash retainer, a one-time initial restricted stock unit (RSU) grant valued at $360,000 vesting in three equal annual installments, and an annual RSU grant valued at $180,000. All equity awards accelerate fully upon a sale of the Company. The Company will also enter into its standard indemnification agreement with her. The filing discloses no related-person transactions above $120,000 and no arrangements under which she was selected as a director. Overall, the disclosure is routine and unlikely to be material to the valuation of the stock.

Nov 1, 2023 8-K